[ACRS] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -27.35%
YoY- -0.40%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 9,282 19,018 1,659 1,449 983 1,628 684 54.41%
PBT -29,261 -19,952 -21,146 -10,659 -23,138 -32,740 -18,192 8.23%
Tax -219 1,278 900 -591 32,733 0 0 -
NP -29,261 -21,230 -21,146 -10,659 -55,319 -32,740 -18,192 8.23%
Tax Rate - - - - - - - -
Total Cost 38,543 40,248 22,805 12,108 56,302 34,368 18,876 12.62%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -315.24 -111.63 -1,274.62 -735.61 -5,627.57 -2,011.06 -2,659.65 -29.90%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.41 -0.32 -0.35 -0.25 -1.34 -1.06 -0.63 -6.90%
EPS Diluted -0.41 -0.32 -0.35 -0.25 -1.34 -1.06 -0.63 -6.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.